Close
Help
Need Help?





JOURNAL

Clinical Medicine Insights: Case Reports

666,320 Journal Article Views | Journal Analytics

Treatment with Etanercept in a Patient with Rheumatoid Arthritis-Associated Interstitial Lung Disease

Submit a Paper



Publication Date: 06 Oct 2011

Type: Case report

Journal: Clinical Medicine Insights: Case Reports

Citation: Clinical Medicine Insights: Case Reports 2011:4 49-52

doi: 10.4137/CCRep.S8150

Abstract

We report a case of a 52-year-old woman with a 1-year history of rheumatoid arthritis-associated interstitial lung disease referred to hospital because of aggravated pulmonary symptoms in spite of intensive treatment including prednisone, azathioprine and triptergium glycoside. We subsequently initiated treatment with 25 mg of etanercept, subcutaneously injected twice weekly. Following 6 months of therapy with this agent, sustained improvement in dyspnea, cough was reported by the patient and respiratory function test showed marked improvement. The improvement was confirmed by reduced middle and lower lung markings on chest radiography and high-resolution CT scan. This report suggests etanercept may be effective in the treatment of rheumatoid arthritis-associated interstitial lung disease.


Downloads

PDF  (464.11 KB PDF FORMAT)

RIS citation   (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)

BibTex citation   (BIBDESK, LATEX)

XML






What Your Colleagues Say About Clinical Medicine Insights: Case Reports
The submission process for publication in Clinical Medicine Insights: Case Reports is extremely smooth.  The editors were very fast in their response and provided detailed instructions about all procedures.  They were happy to answer to all our questions.  The whole process was fast and efficient.  Congratulations to Libertas Academica.
Dr Konstantinos Farsalinos (Onassis Cardiac Surgery Center, Kallithea, Greece)
More Testimonials

Quick Links




Follow Us We make it easy to find new research papers.




SUBJECT HUBS
Author Survey Results
author_survey_results
All authors are surveyed after their articles are published. Authors are asked to rate their experience in a variety of areas, and their responses help us to monitor our performance. Presented here are their responses in some key areas. No 'poor' or 'very poor' responses were received; these are represented in the 'other' category.
See Our Results